Quick Answer
NEUROCRINE BIOSCIENCES INC reported Earnings Per Share Diluted of $4.67 per share for the year ending 2025.
- NEUROCRINE BIOSCIENCES INC showed an increase of +41.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), NEUROCRINE BIOSCIENCES INC's Earnings Per Share Diluted has grown by 459.2%.
- Historical annual values: Fiscal year 2025: $4.67 per share | Fiscal year 2024: $3.29 per share | Fiscal year 2023: $2.47 per share | Fiscal year 2022: $1.56 per share | Fiscal year 2021: $0.92 per share | Fiscal year 2020: $4.16 per share | Fiscal year 2019: $0.39 per share | Fiscal year 2018: $0.22 per share | Fiscal year 2017: $1.62 (loss) per share | Fiscal year 2016: $1.63 (loss) per share | Fiscal year 2015: $1.05 (loss) per share | Fiscal year 2014: $0.81 (loss) per share | Fiscal year 2013: $0.69 (loss) per share | Fiscal year 2012: $0.08 per share | Fiscal year 2011: $0.67 per share | Fiscal year 2010: $0.15 (loss) per share | Fiscal year 2009: $1.30 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: